Sartorius Stedim BioOutsource Scoop Life Science Company of the Year Award

On Wednesday 19th  April 2017, Sartorius Stedim BioOutsource  were named as Scottish Life Sciences Company of the Year at the Made in Scotland awards. The annual Made in Scotland awards rewards Scottish companies that have innovative products and services and have subsequently found success domestically and internationally. We were delighted to be announced as the winner More

Biosimilars: Lessons Learned

Register for our webinar on the 29th of June 2017  to find out from our experts how a Quality by Design approach can de-risk biosimilar development.

Is ADCC the biggest challenge to your biosimilar?

It’s not as easy as ADCC…Avoid costly pitfalls during the development of your biosimilar by accurately determining ADCC activity. Watch our video to learn how ADCC assays can help unpick the issues of similarity between innovator and biosimilar drugs.

Expansion of Sartorius Stedim Cellca

• Biopharma provider purchases property in Science Park III of Ulm • Laboratory and office facility to be constructed on the site by 2019 Göttingen/Laupheim, December 14, 2016 – Sartorius Stedim Cellca based near Ulm in southern Germany, continues on the growth track. At the end of November, the company in its eleventh year since More

Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory

New services to enable U.S. biopharmaceutical companies to accelerate development of biosimilar. Goettingen, Germany | Boston, MA, USA – November 10, 2016: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, opened a new bioanalytical and biosafety testing laboratory yesterday in the major biotech hub of Boston, Massachusetts. This dedicated bioanalytical laboratory More

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.